Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Dermoscopy helps distinguish between scarring and non-scarring hair loss and accurately diagnoses hair and scalp conditions without needing hair plucking.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Middle-aged women with cicatricial alopecia/lichen planopilaris responded well to treatments like ketoconazole shampoo and steroids.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Dermoscopy is useful for diagnosing different types of hair loss.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Stem cell serum can regrow eyebrow hair in chronic cases and prevent hair loss if used early after trauma.